| Literature DB >> 29904652 |
Edison F Paiva1, James H Paxton2, Brian J O'Neil2.
Abstract
The data presented in this article are related to the research article, "The Use of End-Tidal Carbon Dioxide (ETCO2) Measurement to Guide Management of Cardiac Arrest: A Systematic Review" [1]. This article is a systematic review and meta-analysis of existing data on the subject of whether any level of end-tidal carbon dioxide (ETCO2) measured during cardiopulmonary resuscitation (CPR) correlates with return of spontaneous circulation (ROSC) or survival in adult patients experiencing cardiac arrest in any setting. These data are made publicly available to enable critical or extended analyses.Entities:
Keywords: Advanced cardiac life support; Capnography; Cardiac arrest; End tidal carbon dioxide; Meta-analysis; Prognostication; Systematic review
Year: 2018 PMID: 29904652 PMCID: PMC5998212 DOI: 10.1016/j.dib.2018.04.075
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Flow diagram of search results.
Fig. 2Forest plot of the correlation between ETCO2 and ROSC: A. Initial ETCO2 ≥ 10 mmHg; B. Initial ETCO2 ≥ 20 mmHg; C. 20-min ETCO2 ≥ 10 mmHg; D. 20-min ETCO2 ≥ 20 mmHg.
Fig. 3Forest plot of the correlation between specific ETCO2 levels and survival to hospital discharge: A. Initial ETCO2 ≥ 10 mmHg; B. Initial ETCO2 ≥ 20 mmHg; C. 20-min ETCO2 ≥ 10 mmHg; D. 20-min ETCO2 ≥ 20 mmHg.
Characteristics of the included studies.
| Ahrens 2001 | Prospective cohort | 127 | IHCA and Helicopter | 76.0 | 24.0 | Capnography | Initial, 5, 10, 15, 20 min, and final (≥ 10 and ≥ 20) | ROSC | ETCO2 ≥ 20 mmHg at 5 and 10 min – 94.4% of survival | Convenience sampling 14% have already achieved ROSC | Yes | 43% ROSC | |
| 31.5% STFH | |||||||||||||
| STFH | ETCO2 ≤ 17.5 mmHg at 15 min – 91.9% of non-survival | 13.7% SHD | |||||||||||
| SHD | |||||||||||||
| Callaham 1990 | Prospective cohort | 55 | OHCA | 10.9 | 54.5/34.6 | Capnometry | Initial (≥ 10 and ≥ 20) | ROSC | ETCO2 ≥ 15 mmHg predicted ROSC (sensitivity 71% and specificity of 98%) | Rescuers not blinded | Yes | 25.5% ROSC | |
| Small number of patients | |||||||||||||
| Cantineau 1996 | Prospective cohort | 120 | OHCA | 6.3 | 90.6/3.1 | Capnometry | Initial and maximum (≥ 10) | ROSC | ETCO2 ≥ 10 mmHg predicted ROSC (sensitivity 87% and specificity of 74%) | 90.6% asystole | Yes | 31.7% ROSC | |
| Wayne 1995 | Prospective cohort | 90 | OHCA | 0.0 | 0.0/100.0 | Capnography | 20 min (≥ 10) | ROSC | ETCO2 ≥ 10 mmHg predicted ROSC (sensitivity 97.3% and specificity 100.0%) | Only PEA | Yes | 17.8% ROSC | |
| SHA | |||||||||||||
| 14.4% SHA | |||||||||||||
| SHD | |||||||||||||
| 7.8% SHD | |||||||||||||
| Levine 1997 | Prospective cohort | 150 | OHCA | 0.0 | 0.0/100.0 | Capnography | 20 min (≥ 10) | ROSC | ETCO2 ≤ 10 mmHg predicted non-survival (sensitivity 100% and specificity of 100%) | Only PEA Includes data from Wayne's study | Yes | 23.3% ROSC | |
| SHD | |||||||||||||
| 10.7% SHD | |||||||||||||
| Sanders 1989 | Prospective cohort | 35 | IHCA | 47.3 | 27.1/25.6 | Capnometry | Average (≥ 10) | ROSC | All patients with ROSC had average ETCO2 ≥ 10 mmHg | Small number of patients | No | 25.7% ROSC | |
| SHD | |||||||||||||
| 8.6% SHD | |||||||||||||
| Salen 2001 | Prospective cohort | 53 | IHCA | 0.0 | 0.0/100.0 | Capnography | Initial (≥ 16) | SHA | ETCO2 ≥ 16 mmHg associated with survival to admission | Convenience sampling | No | 11.3% SHA | |
| Small number of patients | |||||||||||||
| Eckstein 2011 | Retrospective cohort | 3121 | OHCA | 16.9 | NA | Capnography | Initial (≥ 10 and ≥ 20) | ROSC | ETCO2 ≥ 10 mmHg associated with ROSC (OR 4.79; 95% CI 3.10 to 4.42) | Retrospective large study, but an unreliable OR is provided | No | 22.4% ROSC | |
| Asplin 1995 | Prospective cohort | 27 | OHCA | 48.2 | NA | Capnography | 1 and 2 min (No specific cut-off) | ROSC | Higher ETCO2 levels in ROSC vs. non-ROSC (23.0 vs. 13.2 at 1 min, 26.8 vs. 15.4 at 2 min) | Convenience sampling | No | 51.9% ROSC | |
| SHD | |||||||||||||
| Small number of patients | |||||||||||||
| 11.1% SHD | |||||||||||||
| Grmec 2001 | Prospective cohort | 139 | OHCA | 40.3 | 51.8/7.9 | Capnometry | Initial, final and average (≥ 10) | ROSC | ETCO2 ≥ 10 mmHg predicted ROSC (sensitivity 100.0% and specificity of 74.1%, 81.4%, and 90.0%, respectively for initial, average, and final ETCO2) | – | No | 38.1% ROSC | |
| SHD | |||||||||||||
| 16.6% SHD | |||||||||||||
| Grmec 2003 | Prospective cohort | 185 | OHCA | 76.2 | 23.8 | Capnometry | Initial, final and average (≥ 10) | ROSC | Average and final ETCO2 higher in ROSC patients. Initial ETCO2 higher in ROSC patients only if cardiac origin | Includes data from Grmec 2001 | No | 64.3% ROSC | |
| SID | |||||||||||||
| 24.3% SID | |||||||||||||
| Grmec 2007 | Prospective cohort | 389 | OHCA | 40.1 | 40.9/19.0 | Capnometry | Initial, final and average (≥ 10) | ROSC | Initial ETCO2 ≥ 10 mmHg associated with ROSC | Includes data from Grmec 2003 | No | 60.9% ROSC | |
| SHA | |||||||||||||
| 50.1% SHA | |||||||||||||
| SHD | |||||||||||||
| 21.1% SHD | |||||||||||||
| Heradstveit 2012 | Retrospective cohort | 575 | OHCA | 34.4 | 46.3/19.3 | Capnography | Average, minimum and maximum (No specific cut-off) | ROSC | ETCO2 higher in ROSC patients | Retrospective | No | 49.7% ROSC | |
| SHA | |||||||||||||
| 40.4% SHA | |||||||||||||
| Kolar 2008 | Retrospective cohort | 737 | OHCA | 41.2 | 38.4/20.4 | Capnometry | 20 min (≥ 14.3) | ROSC | ETCO2 ≥ 14.3 mmHg predicted ROSC (sensitivity 100% and specificity 100%), | Retrospective Includes data from Grmec 2001, 2003, and 2007 | No | 59.4% ROSC | |
| SHA | |||||||||||||
| 54.6% SHA | |||||||||||||
| SHD | |||||||||||||
| 23.1% SHD | |||||||||||||
| Lah 2011 | Prospective cohort | 114 | OHCA | 55.3 | 44.7 | Capnometry | Initial and every 1 min (No specific cut-off) | ROSC | Higher initial ETCO2 for those with ROSC if primary cardiac arrest (34.6 vs. 24.7 mmHg) | Comparison between asphyxial and cardiac origin of the arrest | No | 63.2% ROSC | |
| SID | |||||||||||||
| 52.6% SID | |||||||||||||
| SHD | 29.8% SHD | ||||||||||||
| Mauer 1998 | Prospective cohort | 120 | OHCA | 49.1 | 17.9/33.0 | Capnometry | Initial and every 2 min (≥ 15.0) | ROSC | All admitted patients had an ETCO2 ≥ 15 mmHg | ETCO2 was a secondary endpoint | No | 57.5% ROSC | |
| SHA | |||||||||||||
| 27.5% SHA | |||||||||||||
| SHD | |||||||||||||
| 10.8% SHD | |||||||||||||
| Rognås 2014 | Prospective cohort | 271 | OHCA | NA | NA | Capnography | Initial (≥ 10) | ROSC | 4/22 patients with ETCO2 ≤ 10 mmHg had ROSC. | 23% lacking measurements | No | 4 of 22 patients (18.2%) had ROSC with ETCO2 ≤ 1.3 kPa | |
| No specific cut-off should be used during resuscitation | |||||||||||||
ETCO2, end-tidal CO2; NA, not available; IHCA, in-hospital cardiac arrest; OHCA, out-of-hospital cardiac arrest; OR, odds ratio; PEA, pulseless electrical activity; ROSC, return of spontaneous circulation; VF, ventricular fibrillation; VT, ventricular tachycardia; ROSC, return of spontaneous circulation; STFH, survival to twenty-four hours following cardiac arrest; SHA, survival to hospital admission; SID, survival to intensive care unit discharge; SHD, survival to hospital discharge.
Includes asystole, PEA, and 14% in supraventricular tachycardia with a pulse, after intubation and first ETCO2 measurement.
Includes asystole and PEA.
Upper limit of confidence interval lower than OR.
Summary of findings: ETCO2 higher vs. ETCO2 lower than 10 or 20 mmHg for predicting outcome following cardiac arrest.
| 3 | observational studies | serious | not serious | not serious | not serious | very strong association | 80/134 (59.7%) | 16/140 (11.4%) | OR 10.7 (5.6–20.3) | 483 more per 1000 (from 326 more to 620 more) | LOW | CRITICAL |
| dose response gradient | ||||||||||||
| 2 | observational studies | serious | not serious | not serious | not serious | very strong association | 34/42 (81.0%) | 32/136 (23.5%) | OR 12.2 (5.1–29.2) | 574 more per 1000 (from 406 more to 675 more) | LOW | CRITICAL |
| 3 | observational studies | very serious | serious | not serious | not serious | very strong association | 64/79 (81.0%) | 1/215 (0.5%) | OR 181.6 (40.1–822.6) | 805 more per 1000 (from 351 more to 966 more) | LOW | CRITICAL |
| all plausible residual confounding would reduce the demonstrated effect | ||||||||||||
| 1 | observational study | serious | not serious | not serious | not serious | very strong association | 12/13 (92.3%) | 2/41 (4.9%) | OR 234,0 (19.5–2811.4) | 874 more per 1000 (from 451 more to 944 more) | LOW | CRITICAL |
| 1 | observational study | serious | not serious | not serious | not serious | very strong association | 14/68 (20.6%) | 1/45 (2.2%) | OR 11.4 (1.4–90.2) | 184 more per 1000 (from 9 more to 650 more) | LOW | CRITICAL |
| 1 | observational study | serious | not serious | not serious | not serious | very strong association | 12/34 (35.3%) | 3/79 (3.8%) | OR 13.8 (3.6–53.4) | 315 more per 1000 (from 86 more to 640 more) | LOW | CRITICAL |
| 1 | observational study | serious | not serious | not serious | serious | none | 4/25 (16.0%) | 1/28 (3.6%) | OR 5.1 (0.5–49.5) | 123 more per 1000 (from 18 fewer to 611 more) | VERY LOW | CRITICAL |
| 1 | observational study | serious | not serious | not serious | not serious | very strong association | 4/12 (33.3%) | 1/41 (2.4%) | OR 20,0 (2.0–203.3) | 309 more per 1000 (from 23 more to 811 more) | LOW | CRITICAL |
All observational studies start with low quality ratings, and we have decided not to downgrade on risk of bias because of the very strong association between higher ETCO2 levels and ROSC or survival at discharge.
Ahrens [3].
Callaham [4].
Cantineau [5].
Convenience sampling, with 14% having already achieved ROSC.
Small number of patients.
Levine [7].
Wayne [6].
Includes data from previous study.
high heterogeneity (I2 = 78%).
Large confidence interval that crosses 1.0.
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |